Multiple members of The Obesity Society (TOS) unveiled new research about several anti-obesity medications in development at this year’s annual meeting of the American Diabetes Association (ADA) held June 23–26.
PDX engraftment predicts high recurrence and poor survival in triple-negative breast cancer
Researchers examine the association between patient-derived xenograft with recurrence and survival rates in triple negative breast cancer patients.